Category: Approval/Launch Region: Asia · India Company: Cadila Healthcare Ltd

Cadila launches ThRabis, worlds first novel three-dose rabies vaccine

Cadila launches ThRabis, worlds first novel three-dose rabies vaccine
All existing rabies vaccine regimens require five injections spread over 28 days to complete the full regimen. In an important breakthrough pharma major Cadila Pharmaceuticals has developed a novel three-dose recombinant nano-particle based rabies G protein vaccine. Aiming at a Rabies-Free India the novel vaccine was launched by Cadila this month with the campaign

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!